Alpha-1 Antitrypsin Testing
Alpha-1 antitrypsin (AAT) testing is a medical procedure used to diagnose and monitor alpha-1 antitrypsin deficiency, a genetic disorder that affects the lungs and liver.
Purpose of Testing
The primary purpose of AAT testing is to:
- Diagnose alpha-1 antitrypsin deficiency in individuals with symptoms such as chronic obstructive pulmonary disease (COPD), emphysema, or liver disease.
- Identify carriers of the defective gene who may be at risk of passing it to their offspring.
- Monitor the effectiveness of treatment in individuals with alpha-1 antitrypsin deficiency.
Types of Tests
There are several types of AAT tests, including:
- Blood tests: Measure the level of AAT in the blood. Low levels may indicate alpha-1 antitrypsin deficiency.
- Genetic testing: Analyzes the genes that code for AAT to identify mutations associated with the deficiency.
- Pulmonary function tests: Assess lung function and detect any abnormalities that may be related to alpha-1 antitrypsin deficiency.
How the Test is Performed
AAT testing typically involves a blood sample, which is drawn from a vein in the arm. The sample is then sent to a laboratory for analysis.
Interpretation of Results
The results of AAT testing are interpreted as follows:
- Normal levels: Indicate that the individual does not have alpha-1 antitrypsin deficiency.
- Low levels: May indicate alpha-1 antitrypsin deficiency, and further testing may be necessary to confirm the diagnosis.
- Genetic mutations: Identify the specific mutation associated with alpha-1 antitrypsin deficiency.
Risks and Limitations
AAT testing is generally a safe procedure, but there are some risks and limitations to consider:
- Bleeding or bruising: May occur at the site of blood draw.
- Infection: Rarely, infection may occur if the skin is not properly cleaned before the blood sample is taken.
- False-negative results: May occur in some cases, particularly if the individual has a mild deficiency or is a carrier of the defective gene.
What to Expect After Testing
If alpha-1 antitrypsin deficiency is diagnosed, treatment may involve:
- Augmentation therapy: Involves intravenous infusion of AAT to increase levels in the blood.
- Lung protection: Includes measures such as avoiding smoking and air pollution to reduce further lung damage.
- Monitoring: Regular follow-up appointments with a healthcare provider to monitor lung function and adjust treatment as needed.
Article last updated on: 15th June 2025.
If you have any feedback, please get in touch.
Diagnosis Pad
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Medical AI Assistant with Differentials, Guidance, Transcriptions, Notes, Medical Encyclopedia and Explainable AI.
Available for iOS, macOS and Android.
Medical Disclaimer
The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. We we do not guarantee, and assume no legal liability or responsibility for the accuracy, currency, or completeness of the information provided.